This content is machine translated Parkinson's disease Individual therapy management for an optimized outcome – an update Parkinson’s disease is one of the most common neurodegenerative diseases, which manifests itself with motor symptoms such as slowness of movement (bradykinesia), tremors at rest (resting tremor) and muscle stiffness...… CME-Test
This content is machine translated Oxidative stress and neurodegeneration Insights and therapeutic strategies for Parkinson’s disease Parkinson’s disease (PD) is a neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Oxidative stress is increasingly being discussed as a key...…
View Post 8 min This content is machine translated Neurology Change of perspective and looking in the same direction The focus of the German Neurological Society’s most successful congress to date with 7300 participants was the motto “Neurology and Immunology – Joint Perspectives”. In addition to (neuro-)immunological topics such...…
View Post 4 min This content is machine translated Parkinson's Pathophysiology, classification and effective treatment strategies Parkinson’s disease is clinically defined by the main motor symptoms resulting from nigrostriatal degeneration. However, it is now assumed that the disease usually consists of several pathologies. What new findings…
View Post 11 min This content is machine translated Parkinson's disease and movement disorders Optimized therapy management for a better quality of life The International Parkinson and Movement Disorder Society (MDS) brings together thousands of clinicians, researchers, trainees and industry supporters each year who are interested in current research and approaches to the…
View Post 8 min This content is machine translated Neurology Expecting the unexpected – a look into the future of diagnostics and therapy As the leading association in the field of neurology, the EAN is always striving to do pioneering work by developing new approaches for the meeting and exchange of scientific knowledge.…
View Post 7 min This content is machine translated Parkinson's disease and movement disorders Digitalization on the rise for effective treatment strategies This year, the congress committee focused on “Technology-supported treatment strategies – current practice and future prospects”. In doing so, they paved the way for new ways of biomarker-based diagnosis of…
View Post 8 min This content is machine translated Neurology News on the management of MS, Alzheimer’s, Parkinson’s, ALS and MG The AAN Annual Meeting is one of the world’s largest gatherings of neurologists. The focus of the exchange is on the latest findings from science and research as well as…
View Post 3 min This content is machine translated Parkinson's Improving the effect of levodopa in the long term The treatment management of idiopathic Parkinson’s syndrome has improved significantly in recent years. Although a causal treatment is still not possible, the disease can now be treated symptomatically. In the…
View Post 4 min This content is machine translated Parkinson's Individualized therapy concepts for a better quality of life Parkinson’s is the second most common neurodegenerative disease. In Switzerland, around 15,000 people are affected – and the trend is rising. Movement disorders such as tremor, rigor or bradykinesia are…
View Post 10 min This content is machine translated Neurology Neurodegenerative diseases in the focus of promising therapies This year’s DGN focused on neurodegenerative diseases, as much development has taken place in this area. Promising therapeutic approaches are on the horizon, and molecular biological research has provided important…
